Curis Lifesciences SME IPO Subscription Status
Curis Lifesciences SME IPO closed on 11 November 2025 with an overall subscription of 74.39x based on shares applied. QIB demand came in at 96.17x, NII at 115.81x, and retail at 44.28x.
Allotment will be finalised on 12 November 2025. The stock is scheduled to list on NSE and BSE on 14 November 2025.
Issue Price
Rs 128.00
GMP Today
Rs 9.00 (+7.03%)
Overall Subscription
74.39x
Issue Size
₹26.14 Cr
Allotment Date
12 Nov 2025
Listing Date
14 Nov 2025
Curis Lifesciences SME IPO Subscription by Amount
Category-wise subscription based on amount applied at issue price Rs 128.00
| Category | Amount Offered | Amount Applied | Subscription |
|---|---|---|---|
| QIB | Rs 5.24 Cr | Rs 503.49 Cr | 96.17x |
| FII | - | Rs 187.28 Cr | - |
| DFI | - | Rs 10.34 Cr | - |
| Mutual Funds | - | - | - |
| Other | - | Rs 305.87 Cr | - |
| NII | Rs 3.94 Cr | Rs 456.59 Cr | 115.81x |
| bNII (above Rs 10L) | Rs 2.63 Cr | Rs 377.75 Cr | 143.73x |
| Corporate | - | Rs 12.54 Cr | - |
| Individual | - | Rs 358.66 Cr | - |
| Other | - | Rs 6.55 Cr | - |
| sNII (Rs 2L to Rs 10L) | Rs 1.31 Cr | Rs 78.84 Cr | 59.99x |
| Corporate | - | Rs 2.53 Cr | - |
| Individual | - | Rs 74.65 Cr | - |
| Other | - | Rs 1.65 Cr | - |
| IND | Rs 9.16 Cr | Rs 405.84 Cr | 44.28x |
| Total | Rs 18.34 Cr | Rs 1,365.91 Cr | 74.47x |
Curis Lifesciences SME IPO Subscription by Applications
Category-wise subscription based on applications received
| Category | Applications Offered | Applications Received | Subscription |
|---|---|---|---|
| QIB | 409 | 44 | 0.11x |
| FII | - | 18 | - |
| DFI | - | 1 | - |
| Mutual Funds | - | - | - |
| Other | - | 25 | - |
| NII | 103 | 5,576 | 54.14x |
| bNII (above Rs 10L) | 69 | 3,605 | 52.25x |
| Corporate | - | 110 | - |
| Individual | - | 3,431 | - |
| Other | - | 64 | - |
| sNII (Rs 2L to Rs 10L) | 34 | 1,971 | 57.97x |
| Corporate | - | 66 | - |
| Individual | - | 1,862 | - |
| Other | - | 43 | - |
| IND | 358 | 15,853 | 44.28x |
| Total | 870 | 21,473 | 24.68x |
What Do These Subscription Numbers Mean?
A subscription of 74.39x by shares means the IPO received bids for 74 times the shares reserved. Allotment odds depend on application count in each category, not share volume.
Here is what each category number tells you:
QIB at 96.17x by shares: This is the strongest signal on the page. QIBs are institutional investors, mutual funds, foreign institutions, and banks. When they subscribe at 96.17x, it reflects serious institutional conviction.
NII at 54.14x by applications: NII includes high net worth individuals applying above Rs 2 lakh. Proportional allotment uses application subscription. bNII came in at 52.25x and sNII at 57.97x by applications. Share subscription was 115.81x. Allotment uses application count, not share volume.
At 44.28x subscription by applications, approximately 1 in 44 retail applicants can expect an allotment (~2% per application). Retail allotment is done by lottery when oversubscribed.
Curis Lifesciences SME IPO Allotment Chances
Allotment odds below use application subscription (number of bids received), not share or amount subscribed.
Retail (IND)
- •Application subscription: 44.28x.
- •Allotment odds: about 1 in 44 (~2% chance per application).
- •Method: Lottery. If allotted, you receive at least one lot.
- •One application per PAN. Multiple eligible accounts in a household can improve overall family odds, not individual odds.
SHNI (Rs 2 lakh to Rs 10 lakh)
- •Application subscription: 57.97x.
- •Allotment odds: about 1 in 58 for a minimum-lot application (~2% of the applied lot on average).
- •Method: Proportional. Shares allotted are based on your bid size, not a lottery.
- •Share subscription was 59.99x. Allotment uses application count, not share volume.
BHNI (above Rs 10 lakh)
- •Application subscription: 52.25x.
- •Allotment odds: about 1 in 52 for a minimum-lot application (~2% of the applied lot on average).
- •Method: Proportional. Shares allotted are based on your bid size, not a lottery.
- •Share subscription was 143.73x. Allotment uses application count, not share volume.
Check the Curis Lifesciences SME IPO Allotment Status page from 12 November 2025 for your allotment result.
Curis Lifesciences SME IPO GMP After Subscription
GMP for Curis Lifesciences SME stands at Rs 9.00 today, giving an estimated listing price of Rs 137.00 per share.
A subscription of 74.39x combined with a GMP of 7.03% is a strong combination heading into listing. QIB demand above 50x in particular tends to support listing sentiment, as institutional investors are seen as informed buyers.
Track live GMP on the Curis Lifesciences SME IPO GMP Today page or the IPOwiz Live IPO GMP Tracker.
Curis Lifesciences SME IPO Day-wise Subscription
| Day | QIB | NII | Retail | Overall |
|---|---|---|---|---|
| Day 1 - 7 Nov 2025 | 8.34x | 1.19x | 0.87x | 3.07x |
| Day 2 - 10 Nov 2025 | 8.34x | 4.06x | 3.80x | 5.15x |
| Day 3 - 11 Nov 2025 | 96.17x | 115.46x | 44.28x | 74.39x |
Curis Lifesciences SME IPO Key Dates
| Event | Date |
|---|---|
| IPO Open Date | 7 November 2025 |
| IPO Close Date | 11 November 2025 |
| Allotment Date | 12 November 2025 |
| Refund Initiation | 13 November 2025 |
| Share Credit to Demat | 13 November 2025 |
| Listing Date | 14 November 2025 |
| Minimum Investment | Rs 2,56,000.00 |
| Lot Size | 1000 shares |
About Curis Lifesciences SME
Curis Lifesciences Limited is a pharmaceutical manufacturing company specializing in a wide range of dosage forms, including tablets, capsules, oral liquids, external preparations, and sterile ophthalmic ointments. The company operates through three main business models: Loan License Manufacturing (job worker for domestic clients), Contract Manufacturing (supplying finished products to domestic suppliers and merchant exporters to countries like Kenya, Nigeria, and the UK), and Direct Export / Own Brand Manufacturing (exporting products under its own brands to regions like Yemen and Kenya). The company's manufacturing facility in Sanand, Gujarat, has significant annual capacities across its various product forms and is utilizing IPO proceeds for major capacity upgrades, construction of a storage facility, and product registrations in new countries.
Understanding Subscription Categories
QIB - Qualified Institutional Buyers
Includes foreign institutional investors, domestic financial institutions, mutual funds, and other qualified institutions. QIB demand is considered the most reliable indicator of institutional confidence in an IPO.
NII - Non-Institutional Investors
High net worth individuals applying above Rs 2 lakh. Divided into bNII (above Rs 10 lakh) and sNII (Rs 2 lakh to Rs 10 lakh). NII allotment is proportional.
IND - Individual Investors
Investors applying up to Rs 2 lakh per PAN. Allotment is by lottery when oversubscribed. Minimum one lot per successful applicant.
Curis Lifesciences SME IPO GMP Today
Live GMP, listing price estimate, and listing gain
Curis Lifesciences SME IPO Allotment Status
Check allotment result on allotment date
Curis Lifesciences SME IPO Details
Financials, peers, strengths, and review
All IPO Subscription Status
Subscription for all active IPOs
Curis Lifesciences SME IPO Subscription FAQs
What is Curis Lifesciences SME IPO subscription status today?
Curis Lifesciences SME IPO subscription closed on 11 November 2025 with overall subscription of 74.39x (by shares) as of 27 June 2026, 2:01 AM IST. QIB 96.17x, NII 54.14x, IND 44.28x.
What is the overall subscription of Curis Lifesciences SME IPO?
Curis Lifesciences SME IPO is subscribed 74.39x overall by shares at close on 11 November 2025. QIB 96.17x, NII 54.14x, and IND 44.28x.
What is Curis Lifesciences SME IPO QIB subscription?
Curis Lifesciences SME IPO QIB (Qualified Institutional Buyers) subscription is 96.17x by shares. QIB includes mutual funds, FIIs, banks, and other institutions.
What is Curis Lifesciences SME IPO IND subscription?
Curis Lifesciences SME IPO IND subscription is 44.28x by applications. Minimum retail bid is up to Rs 2 lakh per PAN.
What is Curis Lifesciences SME IPO NII subscription?
Curis Lifesciences SME IPO NII (Non-Institutional Investors) subscription is 54.14x by applications. NII covers bids above Rs 2 lakh.
What are allotment chances in Curis Lifesciences SME IPO for retail?
At 44.28x subscription by applications, approximately 1 in 44 retail applicants can expect an allotment (~2% per application). Allotment is done by lottery.
When is Curis Lifesciences SME IPO allotment date?
Curis Lifesciences SME IPO allotment date is 12 November 2025. Check Curis Lifesciences SME IPO Allotment Status on IPOwiz from that day using your PAN.
When does Curis Lifesciences SME IPO subscription close?
Curis Lifesciences SME IPO subscription closed on 11 November 2025. No new applications are accepted after the close.
What is Curis Lifesciences SME IPO GMP today?
Curis Lifesciences SME IPO GMP is ₹9 today (+7.03% over issue price ₹128). See live GMP on the Curis Lifesciences SME IPO GMP Today page.
What is Curis Lifesciences SME IPO issue price and lot size?
Curis Lifesciences SME IPO issue price is ₹128 per share. Lot size is 1000 shares. Minimum investment is ₹2,56,000 per lot (minimum 2 lots for SME). Issue size: ₹26.14 Cr.
When is Curis Lifesciences SME IPO listing date?
Curis Lifesciences SME IPO listing date is 14 November 2025 on NSE and BSE. Allotment is on 12 November 2025.
How does subscription affect Curis Lifesciences SME IPO allotment?
Allotment odds in Curis Lifesciences SME IPO depend on application subscription in each category, not share volume. Retail uses lottery when oversubscribed. NII proportional allotment at 54.14x by applications means roughly 1 in 54 for minimum-lot bids; bNII at 52.25x (~1 in 52). At 74.39x overall, competition is very high.
For allotment results from 12 November 2025, visit the Curis Lifesciences SME IPO Allotment Status page. For listing day updates on 14 November 2025, download the IPOwiz App.
Reviewed by Dinesh Agrawal
15+ years in Indian capital markets and IPO research. Subscription data verified before publish.